ATE434446T1 - Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität - Google Patents

Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität

Info

Publication number
ATE434446T1
ATE434446T1 AT04741321T AT04741321T ATE434446T1 AT E434446 T1 ATE434446 T1 AT E434446T1 AT 04741321 T AT04741321 T AT 04741321T AT 04741321 T AT04741321 T AT 04741321T AT E434446 T1 ATE434446 T1 AT E434446T1
Authority
AT
Austria
Prior art keywords
compound
receptor affinity
active substance
substance combination
npy
Prior art date
Application number
AT04741321T
Other languages
English (en)
Inventor
Jover Torrens
Prio Josep Mas
Zueras Alberto Dordal
Soler Xavier Codony
Vidal Ramon Merce
Castrillo Perez Jose Aurelio
Constansa Jordi Frigola
Helmut-Heinrich Buschmann
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of ATE434446T1 publication Critical patent/ATE434446T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
AT04741321T 2003-07-30 2004-07-29 Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität ATE434446T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200301815A ES2228268B1 (es) 2003-07-30 2003-07-30 Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
PCT/EP2004/008514 WO2005014045A1 (en) 2003-07-30 2004-07-29 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity

Publications (1)

Publication Number Publication Date
ATE434446T1 true ATE434446T1 (de) 2009-07-15

Family

ID=34130548

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04741321T ATE434446T1 (de) 2003-07-30 2004-07-29 Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität

Country Status (9)

Country Link
US (1) US20070009597A1 (de)
EP (1) EP1660131B1 (de)
AT (1) ATE434446T1 (de)
AU (1) AU2004262488A1 (de)
CA (1) CA2534099A1 (de)
DE (1) DE602004021704D1 (de)
ES (2) ES2228268B1 (de)
MX (1) MXPA06001230A (de)
WO (1) WO2005014045A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006019831A1 (en) 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis c
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1984351A1 (de) 2006-02-17 2008-10-29 Memory Pharmaceuticals Corporation Verbindungen mit 5-ht6-rezeptor-affinität
JP2009541423A (ja) * 2006-06-23 2009-11-26 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ コリンエステラーゼ阻害剤と５‐ｈｔ６レセプター親和性の化合物との組合せ
EP1953153A1 (de) 2007-01-31 2008-08-06 Laboratorios del Dr. Esteve S.A. Heterocyclyl-substituierte Sulfonamide für die Behandlung von Wahrnehmungsstörungen bzw. Ernährungserkrankungen
EP1953141A1 (de) * 2007-01-31 2008-08-06 Laboratorios del Dr. Esteve S.A. Aryl-substituierte Sulfonamide für die Behandlung von Wahrnehmungsstörungen oder Ernährungskrankheiten
EP2053052A1 (de) 2007-10-23 2009-04-29 Laboratorios del Dr. Esteve S.A. Verfahren zur Herstellung von 6-substituiertem Imidazo[2,1-b]thiazol-5-sulfonylhalogenid
MX2021003904A (es) 2018-10-05 2021-10-26 Annapurna Bio Inc Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor apj.
WO2023044556A1 (en) 2021-09-24 2023-03-30 Enveric Biosciences Canada Inc. Aminated psilocybin derivatives and methods of using

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020326A1 (en) * 1991-05-20 1992-11-26 Marion Laboratories, Inc. Multi-layered controlled release formulation
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
EP0906339A2 (de) * 1996-03-27 1999-04-07 NG, Gordon, Y., K. Antagonisten von rezeptoren und transportmolekülen
CN1800185A (zh) * 2001-06-11 2006-07-12 比奥维特罗姆股份公司 取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ii型糖尿病的药物的应用
EP1450806B1 (de) * 2001-11-09 2009-04-29 Biovitrum AB (publ) Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
ES2187300B1 (es) * 2001-11-14 2004-06-16 Laboratorios Del Dr. Esteve, S.A. Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.

Also Published As

Publication number Publication date
EP1660131B1 (de) 2009-06-24
DE602004021704D1 (de) 2009-08-06
ES2228268A1 (es) 2005-04-01
CA2534099A1 (en) 2005-02-17
AU2004262488A1 (en) 2005-02-17
ES2328485T3 (es) 2009-11-13
EP1660131A1 (de) 2006-05-31
US20070009597A1 (en) 2007-01-11
WO2005014045A1 (en) 2005-02-17
ES2228268B1 (es) 2006-07-01
MXPA06001230A (es) 2006-05-15

Similar Documents

Publication Publication Date Title
ATE509636T1 (de) Kombination aus einem cholinesterase-hemmer und einer verbindung mit 5-ht6-rezeptor-affinität
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
BRPI0411699A (pt) compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos
EA200301215A1 (ru) Лиганды рецепторов 5-ht и их применение
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
NO20034289D0 (no) N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren
DE60212163D1 (de) Kontrolliertes wirkstoffabgabesystem
ATE470662T1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
PL363168A1 (pl) Cyklopentanole, kompozycje zawierające takie związki i sposoby leczenia
DK1300398T3 (da) Propan-1,3-dionderivat
ATE413388T1 (de) Muskarin antagonisten
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
DE60035639D1 (de) Hydroxydiphenyletherverbindungen
HRP20050510A2 (en) Microbicide substances
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
BR9909486A (pt) Compostos calcilìticos
ATE434446T1 (de) Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität
ATE409040T1 (de) Kombination enthaltend substanzen mit npy- rezeptor affinität und substanzen mit 5-ht6- rezeptor affinität
BR9914736A (pt) Compostos de 3-(fenil substituìdo)-5-tienil-1,2,4-triazol com atividade contra mosca branca
TR199901017A2 (xx) B�cek ilac� terkibi.
ATE407133T1 (de) 2-imidazo-benzothiazole als adenosin-rezeptor liganden
TR200202195T2 (tr) 5-Yer değiştirmiş 1-(4-florofenil)-1,3- dihidroizobenzofuran'ın adım adım alkillenmesi
ES2183709B1 (es) Composicion para el control de artropodos.
BRPI0406734A (pt) Composição termiticida, e, método para controlar térmitas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties